Apetito (excesivo)

Aescin is the primary active triterpene saponin extracted from horse chestnut seed and is the constituent responsible for its venoactive and circulatory effects. Clinical trials confirm its ability to improve venous tone, reduce capillary permeability, decrease leg oedema, and relieve symptoms of chronic venous insufficiency. It is recognised by the European Medicines Agency (EMA) and German Commission E for CVI.

Ajoene is one of the most extensively studied natural antiplatelet agents. It inhibits platelet aggregation induced by all known agonists by blocking the GPIIb/IIIa fibrinogen receptor and reducing thromboxane A2 formation. In vitro and animal perfusion chamber studies confirm prevention of thrombus formation at both high and low arterial shear rates.

ALA has demonstrated improvements in endothelial function, microcirculation, and vascular inflammatory markers in multiple RCTs. A meta-analysis context and individual trials in diabetic peripheral neuropathy patients show ALA significantly improves capillary blood flow velocity and endothelium-dependent vasodilation. A double-blind RCT in stroke patients assessed carotid intima-media thickness and flow-mediated dilation.

Allicin is the primary organosulfur compound formed when garlic is crushed, responsible for most of garlic's cardiovascular and circulatory effects. It relaxes blood vessel smooth muscle, inhibits thromboxane A2, enhances NO production, and reduces platelet stickiness. Clinical evidence from garlic supplementation studies (allicin-standardised extracts) demonstrates improvements in blood flow efficiency and blood pressure.

A randomized, controlled, crossover trial in 25 adults at cardiovascular risk found that acute AGIQ ingestion significantly improved endothelial function (likely via flow-mediated dilation) compared to placebo, with no significant change in blood pressure or arterial stiffness. This constitutes the most direct human evidence for a circulatory benefit of AGIQ.

Anthocyanins are flavonoid pigments (found in bilberries, black currants, elderberries, etc.) with established vascular benefits including reduction of blood pressure, improvement of flow-mediated dilation (FMD), reduction of arterial stiffness, and strengthening of capillary walls. A 2023 PMC review of clinical trials confirmed anthocyanins improve multiple vascular and endothelial biomarkers. Their mechanisms include eNOS upregulation, antioxidant protection of blood vessel walls, and anti-platelet effects.

Anthocyanosides (glycosidic forms of anthocyanidins) are the principal active forms of anthocyanins in bilberry and related plants, with documented clinical effects on capillary strength, microcirculation, and venous health. Clinical trials with bilberry extract standardised to anthocyanosides show improvements in capillary permeability, chronic venous insufficiency, and diabetic microangiopathy. They are the primary constituent responsible for bilberry's circulatory properties.

AAKG is a precursor to nitric oxide (NO), a key vasodilatory signaling molecule. Clinical studies confirm AAKG significantly raises plasma L-arginine levels, though observed improvements in brachial-artery blood flow in exercise contexts appear attributable to exercise itself rather than the supplement independently. The L-arginine component still underpins a plausible and studied vascular mechanism.

Aronia melanocarpa has demonstrated improvements in blood circulation parameters in human studies, including inhibition of platelet aggregation and reductions in overall coagulation potential. In a clinical trial in metabolic syndrome patients, 1–2 months of supplementation produced significant inhibition of platelet aggregation and reduced clot formation. Aronia polyphenols may act via ACE inhibition and antioxidant-mediated endothelial protection.

Astaxanthin has documented effects on vascular endothelial function in human studies: it reduces oxidative stress and inflammation biomarkers relevant to atherosclerosis, and RCTs report improvements in endothelial function markers in adults. Evidence from a 2025 comprehensive review confirms improved vascular health outcomes across clinical trials.

AS-IV produces vasorelaxation via the nitric oxide–cGMP pathway in vascular tissue. Astragalus is described in TCM as 'benefiting vital energy and activating blood circulation.' Clinical use is documented for ischemic heart disease and cerebral thrombosis, with vasodilation and improved blood pumping from the heart noted in heart failure studies.

Oral ATP disodium supplementation has clinical evidence supporting improvements in blood flow and vascular function. A human study by Jäger et al. (2014) showed significant increases in brachial artery diameter and blood flow after ATP supplementation measured by flow-mediated dilation. ATP's vasoactive effects are partly mediated by endothelial P2Y receptors triggering release of nitric oxide, prostacyclin, and endothelium-derived hyperpolarizing factor.

Epimedium prenylflavonoids produce NO-dependent vasorelaxation of coronary arteries, upregulate eNOS in endothelial cells, and have demonstrated positive actions on vascular reactivity and endothelial function in human subjects. Epimedium was historically used in TCM for coronary heart disease and hypertension. Thrombosis-reducing activity has also been documented in animal models.

Beetroot-derived nitrate raises plasma nitrite and nitric oxide, promoting vasodilation and improved peripheral and cerebral blood flow. RCTs show reductions in vascular resistance and enhanced tissue oxygenation. Effects are most pronounced in less aerobically fit and older individuals.

Benfotiamine has demonstrated vasculoprotective effects on endothelial function in human clinical studies. In a small RCT of 20 healthy smokers, benfotiamine pretreatment (1050 mg/day for 3 days) prevented the smoking-induced reduction in brachial artery flow-mediated dilation and attenuated the rise in sVCAM-1. A separate small clinical study in 13 T2DM patients showed benfotiamine prevented AGE-meal-induced vascular dysfunction.

Multiple RCTs and meta-analyses demonstrate that berberine significantly lowers LDL cholesterol, total cholesterol, and triglycerides while modestly raising HDL. It also improves endothelial function and vascular elasticity in clinical populations. Effects on blood pressure have been inconsistent across trials.

Bilberry (Vaccinium myrtillus) is rich in anthocyanins, which have been shown to improve microcirculation, strengthen capillary walls, reduce capillary fragility, and support venous health in clinical trials. Studies report benefits in chronic venous insufficiency and diabetic retinopathy, both conditions of compromised vascular function. Bilberry anthocyanins have antioxidant and vasoprotective effects on endothelial cells.

Black tea improves circulation primarily through enhanced endothelial-dependent vasodilation and reduced platelet aggregation. Clinical trial evidence shows improved flow-mediated vasodilation with regular consumption. These effects are mediated by the antioxidant and anti-inflammatory properties of tea polyphenols.

Human RCT evidence indicates blueberry consumption improves endothelial function (flow-mediated dilation) in healthy and at-risk populations, with consistent support across multiple trials. Effects on arterial stiffness exist but are less certain. Mechanistically, improved nitric oxide bioavailability via eNOS activation is the primary pathway.

CoQ10 and taurine in bovine heart have both been linked to endothelial function and circulation. CoQ10 supports NO bioavailability and vasodilation; reduced CoQ10 is associated with endothelial dysfunction. Taurine protects blood vessel integrity and cardiac contractility that drives circulation.

Butcher's Broom (Ruscus aculeatus) contains ruscogenins that act as alpha-adrenergic agonists to increase venous tone and reduce capillary permeability, supporting circulation in chronic venous insufficiency (CVI). Multiple clinical trials confirm its efficacy in reducing leg oedema, heaviness, and CVI symptoms. The European Medicines Agency recognises its traditional and well-established use for venous symptoms.

A 2014 non-randomized controlled human study (Kotaka et al., Biological and Pharmaceutical Bulletin) demonstrated that topical camphor application induced both cold and warm sensations and measurably increased blood flow in skin and muscle. This is one of the few human-subject trials specifically documenting camphor's circulatory effects.

Capsaicin, the active compound in cayenne pepper, promotes vasodilation via TRPV1 receptor activation, triggering release of nitric oxide and calcitonin gene-related peptide (CGRP), a potent peripheral vasodilator. Animal and mechanistic studies robustly support these effects; human data, though limited and mixed in scale, signal modest benefits for peripheral circulation, blood pressure, and platelet function. Traditionally used for millennia for poor circulation.

Capsaicin acts on TRPV1 channels in vascular tissues, stimulating vasodilation via CGRP release from perivascular nerve terminals, which enhances local and cutaneous blood flow. Human studies confirm vasodilatory and thermoregulatory effects, and epidemiological data link habitual chili consumption to reduced cardiovascular mortality.

Capsaicin promotes vasodilation and increases peripheral blood flow via TRPV1 activation and release of vasodilatory neuropeptides. Observational data from Thai populations consuming daily cayenne link regular intake to elevated fibrinolytic activity. Cayenne has also been traditionally used to improve peripheral circulation.

Centella asiatica (Gotu Kola) has clinical evidence for improving microcirculation and venous function in CVI and diabetic microangiopathy, through its triterpene saponins (asiaticoside, madecassoside). RCTs confirm significant improvements in capillary permeability, oedema, and venous hypertension parameters. EMA HMPC recognises its use for venous insufficiency symptoms.

Centella triterpenes (asiaticoside, madecassoside, asiatic acid, and madecassic acid from Centella asiatica) are the primary active compounds responsible for Gotu Kola's documented circulatory effects. RCTs using the total triterpenic fraction of Centella asiatica (TTFCA) at 60–180 mg/day demonstrate significant improvements in capillary permeability, oedema, and venous hypertension in CVI and diabetic microangiopathy patients.

Danshen is one of the most clinically used herbs for improving blood circulation in TCM and modern Chinese medicine, documented across dozens of trials. Its mechanisms include inhibiting platelet aggregation, promoting fibrinolysis, dilating blood vessels via calcium channel inhibition, and improving microcirculation. These actions are well-supported by pharmacological and clinical data.

An RCT found that aronia polyphenol consumption improved arterial function and reduced arterial stiffness in prehypertensive middle-aged adults, with changes linked to gut microbiome modulation. Chokeberry also reduces platelet aggregation and clot formation in metabolic syndrome patients, supporting broader circulatory benefits.

C. sinensis hesperidin and flavanones improve endothelial function (FMD) and reduce vascular inflammatory markers in multiple RCTs, directly relevant to circulation. Orange juice supplementation studies demonstrate vascular benefits in healthy and at-risk adults. Endothelial nitric oxide pathway enhancement is a key mechanism.

Cocoa flavanols robustly improve endothelial function, as measured by flow-mediated dilation (FMD) of the brachial artery, in both healthy individuals and those with cardiovascular risk factors. Products providing ~100 mg epicatechin reliably increase FMD. Cocoa flavanols also improve cerebral and peripheral microvascular function.

Copper supports hematopoiesis and iron metabolism essential for blood oxygenation. Ceruloplasmin, a copper-dependent ferroxidase, is required for iron release from stores and incorporation into hemoglobin. Copper deficiency impairs red blood cell production and can cause anemia, directly impairing circulatory oxygen delivery.

CoQ10 (ubiquinone/ubiquinol) supports circulation by improving endothelial function via enhanced nitric oxide bioavailability, reducing oxidative stress in arterial walls, improving vascular tone, and supporting cardiac output in heart failure. Meta-analyses confirm modest blood pressure reductions and improvements in endothelial function. Its levels decline with age and with statin use, making supplementation particularly relevant in cardiovascular populations.

Cordyceps promotes vasodilation via adenosine and cordycepin-mediated stimulation of endothelial nitric oxide production, improving blood flow. It has shown anti-platelet and fibrinolytic enzyme-supporting effects in preclinical models. Human data from arrhythmia trials and heart failure studies suggest improved cardiac output and vascular function, though direct human evidence on peripheral circulation is modest.

Curcumin, the primary bioactive polyphenol of turmeric, supports vascular circulation by improving endothelial function, reducing arterial stiffness, inhibiting platelet aggregation, and exerting anti-inflammatory effects on vascular walls. A 2017 meta-analysis of RCTs confirmed curcumin supplementation significantly improved flow-mediated dilation (FMD) in patients with metabolic syndrome and other cardiovascular risk conditions.

Blackcurrant anthocyanins have been shown in human RCTs to improve flow-mediated dilation (FMD) and peripheral blood flow. Studies demonstrate increased forearm and femoral artery blood flow with supplementation. WebMD notes limited research suggesting improvement in poor circulation from peripheral artery disease.

DHA is a long-chain omega-3 fatty acid integral to endothelial cell membrane fluidity, NO-dependent vasodilation, and anti-inflammatory signalling. Meta-analyses of combined DHA/EPA supplementation consistently demonstrate blood pressure reductions and improved arterial compliance. DHA specifically improves red blood cell deformability, reduces blood viscosity, and exerts vasodilatory effects via enhanced endothelial NO production.

Diosmin is a flavonoid glycoside (from citrus fruit) with well-documented venoactive properties, widely used clinically for chronic venous insufficiency and related circulatory disorders. When combined with hesperidin (as Daflon), it reduces limb swelling and improves quality of life; large RCTs confirm its efficacy. It is a pharmaceutical standard of care for CVI in many European countries.

Dong Quai has well-documented vasodilatory, antithrombotic, and blood viscosity-reducing properties driven by ligustilide (calcium channel inhibition), coumarin derivatives, and ferulic acid (thromboxane A2 inhibition). These circulatory effects are supported by pharmacological studies and some TCM combination clinical trials, though large-scale monotherapy RCTs are lacking. TCM has used Dong Quai as a 'blood-moving' tonic for thousands of years, specifically targeting peripheral circulation.

DPA inhibits platelet aggregation more efficiently than EPA or DHA, reducing thrombotic risk and improving microcirculatory dynamics. It also promotes endothelial cell migration and VEGF-mediated vascular repair, supporting overall circulatory health. These properties have been demonstrated in vitro and in animal models, with supporting epidemiological associations in humans.

EPA is a long-chain omega-3 polyunsaturated fatty acid that supports vascular circulation through anti-inflammatory eicosanoid production, antithrombotic effects, endothelial NO upregulation, and arterial vasodilation. Clinical meta-analyses of combined EPA/DHA supplementation confirm blood pressure reductions and improvements in arterial compliance, and EPA specifically is associated with reduced cardiovascular event risk at 4 g/day (REDUCE-IT trial, n=8,179).

Flaxseed's bioactive compounds (ALA, SDG lignans, fiber) exert multiple favorable effects on the cardiovascular circulation, including LDL cholesterol reduction, anti-atherosclerotic effects, and platelet activity modulation. A 2018 review in the American Journal of Physiology documented antiatherogenic, antihypertensive, cholesterol-lowering, and anti-inflammatory cardiovascular actions.

Garlic and its active sulfur compounds (allicin, S-allylcysteine) support circulation through vasodilation, blood pressure reduction, antiplatelet effects, and improvement of endothelial function. A completed double-blind RCT (NCT05349253) evaluated fermented garlic extract on cerebral blood flow, finding significant acute increases in regional cerebral and peripheral blood flow alongside carotid artery velocity changes. Epidemiological data show improved blood flow efficiency in high-garlic-consuming populations.

Garlic has documented antiplatelet and blood pressure-lowering effects that collectively support circulatory function. A meta-analysis confirmed garlic reduces SBP by ~8 mmHg and DBP by ~5.5 mmHg in hypertensive individuals. Platelet aggregation inhibition via thromboxane suppression and increased cAMP/cGMP further enhances microcirculatory function.

Ginger (Zingiber officinale) supports circulation through multiple mechanisms: inhibition of platelet aggregation (anti-thrombotic), vasodilation via NO and prostaglandin pathways, and reduction of vascular inflammation. It is a traditional circulatory herb in Ayurvedic, TCM, and European herbal medicine. Clinical studies confirm antiplatelet and mild blood-pressure-lowering effects, improving blood flow at typical dietary and supplemental doses.

Ginkgo biloba extract (GBE) has robust clinical evidence for improving blood flow across multiple vascular beds, including coronary, cerebral, cutaneous, and peripheral circulation. Multiple RCTs in CAD patients and healthy elderly adults demonstrate increased LAD blood flow and improved endothelium-dependent vasodilation. Nine double-blind RCTs in peripheral arterial insufficiency showed significantly increased pain-free and maximum walking distances alongside measurable plethysmographic blood-flow improvements.

Multiple RCTs and a 2025 systematic review and meta-analysis (13 RCTs) demonstrate that ginseng supplementation improves flow-mediated dilation (FMD) and endothelial nitric oxide (eNO) production, key markers of vascular function. Ginsenosides, particularly Rg3, stimulate endothelial eNOS via the PI3K/Akt pathway, promoting vasodilation and inhibiting platelet aggregation. Clinical evidence also suggests reductions in arterial stiffness and improved coronary blood flow, though large-scale cardiovascular outcome trials remain sparse.

Gotu Kola (Centella asiatica) and its triterpene compounds (asiaticoside, madecassoside, asiatic acid) have documented clinical benefits for chronic venous insufficiency and microangiopathy. Multiple RCTs in CVI patients show improvements in capillary permeability, oedema, ankle swelling, and venous hypertension. The European Medicines Agency has recognised Centella asiatica preparations for venous insufficiency.

Multiple clinical trials show grape seed OPCs improve microcirculatory parameters, capillary resistance, and reduce symptoms of chronic venous insufficiency. A pilot MRI study found GSE significantly increased inferior vena cava blood flow. GSE promotes endothelium-dependent vasodilation via nitric oxide pathways. Doses of 100–300 mg/day OPCs have been used in controlled trials.

GSE's OPCs strengthen capillary walls, reduce vascular permeability, and improve blood flow. RCTs and pilot studies using 4D-flow MRI have shown increased venous blood flow velocity in chronic venous insufficiency patients. Traditional European use of grape sap and leaves for circulatory complaints predates modern research by centuries.

Hawthorn (Crataegus spp.) extracts, standardised to oligomeric procyanidins and flavonoids, have documented cardioprotective and peripheral vascular benefits. Multiple clinical trials confirm efficacy in heart failure and suggest peripheral vasorelaxation and blood pressure reduction via nitric oxide-dependent and independent mechanisms. German Commission E has approved hawthorn for cardiac insufficiency and circulatory support.

Hesperetin supports microcirculation and venous function. Human studies show improvements in microvascular reactivity and endothelial responses with hesperidin/hesperetin intake. In venoactive clinical combinations, hesperetin contributes to improved leg comfort and venous circulation.

Hesperidin is a well-established venotonic agent used clinically, typically in combination with diosmin, for chronic venous insufficiency (CVI) and microcirculatory disorders. It reduces venous inflammation, improves capillary permeability, and reduces edema. The diosmin/hesperidin combination is considered a standard reference therapy for CVI in clinical trials.

Hibiscus sabdariffa exerts vasodilatory and mild diuretic effects that improve circulatory dynamics, primarily via ACE inhibition and modulation of aldosterone activity. Animal studies show it reduces cardiac hypertrophy and oxidative stress. Human evidence is largely derived from blood pressure trials showing improved vascular tone.

Horse chestnut seed extract (HCSE), standardised to escin (aescin), has well-established clinical evidence for improving venous circulation, particularly in chronic venous insufficiency (CVI). A Cochrane review of 17 RCTs found HCSE significantly reduced leg oedema and venous symptoms. It is considered equivalent to compression stockings for reducing peripheral oedema in CVI.

Jiaogulan promotes circulation via endothelial nitric oxide production, which dilates blood vessels, and by inhibiting platelet aggregation, reducing the risk of abnormal clot formation. These effects are supported by in vitro studies on gypenosides and multiple cardiovascular clinical studies.

Knotweed's trans-resveratrol enhances blood flow through vasodilation (via eNOS and nitric oxide), reduces blood viscosity, inhibits platelet aggregation, and improves endothelial function. In Japanese Kampo medicine, knotweed preparations were specifically used to stimulate circulation. Human trials confirm resveratrol improves flow-mediated dilation.

Kudzu root and puerarin are well-documented to dilate coronary and cerebral arteries, improve microcirculation, and enhance blood flow. These vasodilatory effects underpin much of kudzu's cardiovascular use in Chinese medicine and are supported by both preclinical evidence and clinical application in China for circulatory disorders.

L-arginine is the direct precursor to endothelium-derived nitric oxide (NO), a critical vasodilator regulating vascular tone and blood flow. Clinical meta-analyses confirm daily intakes of 4.5–21 g increase flow-mediated vasodilation (FMD) and reduce pulse-wave velocity. However, a major 6-month RCT (NO-PAIN, n=133 PAD patients, 3 g/day) found no long-term benefit on FMD, possibly due to 'arginine paradox,' indicating benefits may be context- and dose-dependent.

Clinical trials and systematic reviews document that propionyl-L-carnitine, an acyl derivative, reduces symptoms of peripheral artery disease and intermittent claudication. The NIH ODS notes a systematic review of three RCTs (n=456) where propionyl-L-carnitine improved peak walking time and reduced pain. L-carnitine also supports endothelial integrity and microvascular function.

L-citrulline is converted by the kidneys to L-arginine, bypassing first-pass hepatic metabolism and more effectively raising plasma arginine levels than L-arginine supplementation alone. A comprehensive review of 43 studies confirmed L-citrulline and L-arginine supplementation improves endothelial-dependent vasodilation and blood pressure at doses ≥6 g/day. L-citrulline demonstrates superior bioavailability to L-arginine for NO-mediated vascular effects.

Oligonol (lychee-derived polyphenol) has been shown in clinical research to support peripheral blood flow and microcirculation, including in people with cold sensitivity and poor peripheral circulation. A 2020 RCT specifically assessed effects of a standardized lychee oligomerized polyphenol formulation on peripheral circulation and cold sensitivity. Oligonol's microcirculation enhancement is cited as a primary mechanism underlying its skin and exercise performance benefits.

TC improved endothelial dysfunction in a 12-week human RCT in diabetic patients, with improved nitric oxide levels and reduced endothelial dysfunction markers. Its inhibition of vascular smooth muscle cell proliferation relevant to atherosclerosis is well documented in preclinical studies.

Naringin improves endothelial function, endothelium-dependent vasorelaxation, and arterial stiffness in preclinical and limited human studies. A 2025 systematic review of 62 studies confirmed vasoprotective effects and reported human trial evidence for reduced pulse wave velocity and improved lipid profiles. Mechanistic action involves PI3K/Akt, NF-κB, Nrf2, and renin-angiotensin system modulation.

Nattokinase is a fibrinolytic serine protease from fermented soybean (natto) with demonstrated antithrombotic and blood-flow-enhancing effects in humans. A double-blind crossover study in 12 healthy males showed a single oral dose of 2,000 FU significantly elevated fibrinolysis markers and prolonged clotting time. A 2024 systematic review and meta-analysis of 6 RCTs (546 participants) confirmed cardiovascular benefits, and a clinical study of 1,062 participants at 10,800 FU/day showed effective management of atherosclerosis.

Nattokinase reduces whole blood viscosity and red blood cell aggregation in a dose-dependent manner, and has been shown to improve blood flow in human subjects. Its fibrinolytic and antiplatelet mechanisms collectively support improved microcirculatory and macrocirculatory conditions.

Omega-3 fatty acids (primarily EPA and DHA) support circulation through anti-inflammatory, antithrombotic, and vasodilatory mechanisms. A landmark meta-analysis of 70 RCTs (>5,000 participants) found omega-3 supplementation (1–4 g/day) reduced systolic BP by 4.5 mmHg and diastolic BP by 3 mmHg. EPA and DHA improve endothelial function, increase NO production, reduce platelet aggregation, and improve arterial compliance.

Onion improves circulation through vasodilatory, antiplatelet, and antihypertensive mechanisms. Prostaglandin A in onion relaxes and widens blood vessels, reducing peripheral blood flow resistance. Quercetin inhibits platelet aggregation, reducing thrombotic risk.

Hesperidin from orange improves microvascular endothelial function, supports venous tone, and enhances peripheral circulation. Clinical RCTs show improvements in endothelial function measured by flow-mediated dilation. The diosmin+hesperidin combination (partially orange-derived) has strong clinical support for chronic venous insufficiency.

Early clinical studies reported that pantethine reduces platelet aggregation and favorably modifies platelet phospholipid composition in dyslipidemic patients, effects that are independent of lipid lowering. Pantethine has also been shown to promote healthy fatty acid incorporation into blood cell membranes, potentially improving red blood cell deformability. These antiplatelet observations, while not replicated in large modern RCTs, originate from published peer-reviewed sources.

Parsley supports vascular circulation through antihypertensive, antithrombotic, and vasodilatory actions demonstrated preclinically. Apigenin promotes nitric oxide production, calcium channel relaxation, and reduced platelet aggregation. Parsley's folate and vitamin K further contribute to vascular wall integrity and anti-calcific properties.

Pine bark extract is well-documented to improve endothelial function, enhance microcirculation, reduce venous edema, and improve venous tone in chronic venous insufficiency. Multiple RCTs demonstrate improved blood flow and reduced symptoms of poor circulation. It is one of the best-studied indications for Pycnogenol.

Pine bark extract (primarily Pycnogenol® from French maritime pine) is among the most studied plant extracts for circulation, with 35+ years of research demonstrating improved blood flow, strengthened venous walls, reduced oedema, and improved microcirculation in chronic venous insufficiency. A key RCT (n=86 severe CVI patients) showed pine bark extract outperformed diosmin-hesperidin for reducing capillary filtration, oedema, and skin changes, and improving tissue oxygenation.

Multiple double-blind, placebo-controlled RCTs have assessed policosanol in patients with intermittent claudication, a condition of impaired peripheral circulation. Significant improvements in both initial and absolute claudication walking distances have been documented. The proposed mechanism involves antiplatelet activity and improved endothelial function.

Clinical trials show pomegranate improves endothelial function, reduces arterial stiffness, and increases nitric oxide bioavailability, supporting overall vascular circulation. A 2012 Queen Margaret University study in 60 volunteers demonstrated significant reduction in pulse wave velocity and blood pressure. Mechanisms include upregulation of eNOS and antioxidant protection of NO.

Pycnogenol (French maritime pine bark extract) has over 35 years of research confirming its ability to improve blood flow, strengthen venous walls, and reduce symptoms of chronic venous insufficiency. A prospective controlled study of 86 patients with severe CVI demonstrated Pycnogenol (150–300 mg/day) outperformed diosmin-hesperidin (Daflon) in reducing oedema, skin flux, and capillary filtration while improving tissue oxygenation. It upregulates endothelial nitric oxide synthase, promoting vasodilation.

Quercetin is a flavonol present in onions, apples, and many plants with documented circulatory benefits including blood pressure reduction, improved endothelial function via NO upregulation, anti-platelet effects, and reduction of vascular inflammation. A meta-analysis of RCTs found quercetin supplementation (>500 mg/day) significantly reduced systolic blood pressure. It is among the most studied flavonoids for vascular health.

RYR has documented effects on vascular function including improvements in endothelial function, reduction of carotid intima-media thickness (IMT), and anti-atherosclerotic actions in clinical populations. Traditional Chinese medicine documented its use specifically for 'promoting blood circulation and releasing stasis' since at least the Ming Dynasty. Clinical meta-analyses confirm anti-atherosclerotic benefit, and human trials show improved endothelial markers.

Resveratrol, a stilbenoid polyphenol from grapes and red wine, supports vascular circulation by stimulating endothelial nitric oxide synthase (eNOS), reducing oxidative stress, inhibiting platelet aggregation, and improving arterial compliance. Clinical trial results on vascular biomarkers are contrasting and often null at high supplemental doses; effects from food-source (red wine) consumption at lower doses have shown significant improvements in endothelial function.

Ruscogenins are the primary active steroidal saponins in Butcher's Broom (Ruscus aculeatus) responsible for its venoactive effects on circulation. They act as alpha-1 adrenergic receptor agonists to increase venous tone and reduce capillary permeability. Clinical evidence for ruscogenin-standardised Butcher's Broom preparations supports reduction of oedema and CVI symptoms. EMA and ESCOP recognise ruscogenins as the markers for standardisation of Butcher's Broom.

Rutin is a flavonoid glycoside (quercetin-3-rutinoside) found in buckwheat, citrus, and other plants, with recognised venoactive properties that improve venous tone, reduce capillary fragility, and decrease capillary permeability. It is listed by ConsumerLab and pharmacopoeia references as a venoactive compound for chronic venous insufficiency. As a structural analogue of troxerutin, it shares pharmacological mechanisms with established venous circulation drugs.

Safflower (Hong Hua) has been used in TCM for over 2,500 years to promote blood circulation and remove blood stasis. Modern studies confirm that HSYA and safflower flavonoids dilate blood vessels, enhance peripheral blood flow, inhibit platelet aggregation, and improve microcirculation. These effects are confirmed in animal and in vitro studies and underpin its cardio- and cerebrovascular clinical applications.

Serratiopeptidase's fibrinolytic and anti-inflammatory properties have been proposed to support circulation by degrading intravascular fibrin deposits, reducing vascular inflammation, and improving microcirculation in edematous tissue. A 2023 PMC mouse model study demonstrated SRP attenuates LPS-induced vascular inflammation. Clinical evidence for circulation specifically is indirect, embedded within anti-edemic and fibrinolytic data.

S. japonica is listed in TCM as one of the 50 fundamental herbs specifically for circulatory system health. Rutin strengthens capillaries and improves blood flow. Troxerutin and hydroxyethylrutosides (rutin derivatives from S. japonica) have clinical evidence for improving venous circulation in chronic venous insufficiency.

Nitrate in spinach is converted to nitric oxide, which increases endothelial flow-mediated dilation (FMD) and reduces vascular resistance. An RCT demonstrated that spinach intake increased plasma nitrite and significantly improved FMD of the brachial artery vs. control, supporting improved peripheral circulation.

Szechuan lovage is one of the most extensively researched TCM herbs for promoting blood circulation. Its bioactive compound tetramethylpyrazine (TMP/ligustrazine) dilates blood vessels, improves microcirculation, and reduces hemorheological abnormalities. Multiple pharmacological and clinical studies support its use in blood stasis syndromes across cardio-cerebrovascular contexts.

Multiple meta-analyses of RCTs confirm taurine significantly reduces systolic and diastolic blood pressure, improves left ventricular ejection fraction, and reduces heart rate. Taurine stimulates endothelial nitric oxide synthase to promote vasodilation and exerts antioxidant effects on the vasculature.

T. arjuna bark demonstrates clinically documented positive inotropic activity, coronary vasodilatory effects, and mild antithrombotic/antiplatelet properties that collectively support circulatory function. Animal studies show increased coronary artery flow. A clinical study found reduced platelet count and improved blood pressure in coronary artery disease patients.

Troxerutin (O-β-hydroxyethyl rutin) is a semi-synthetic flavonoid venoactive drug used clinically in Europe and Asia for chronic venous insufficiency and microcirculatory disorders. Multiple RCTs have confirmed its efficacy in reducing leg oedema, capillary permeability, and venous symptoms. It was the reference comparator in four of the 17 horse chestnut Cochrane RCTs, demonstrating clinical-grade activity for venous circulation.

Turmeric (Curcuma longa) root contains curcuminoids that improve endothelial function, reduce arterial stiffness, inhibit platelet aggregation, and decrease vascular inflammation. Meta-analyses of RCTs confirm curcumin/turmeric supplementation improves flow-mediated dilation in subjects with metabolic syndrome. Turmeric has been used in Ayurvedic and TCM for 4,000+ years for circulatory and blood conditions.

Vinpocetine, a semi-synthetic vinca alkaloid derived from vincamine, enhances cerebral blood flow by inhibiting phosphodiesterase type 1, reducing blood viscosity, and improving red blood cell deformability. It has been used as a prescription drug in Eastern Europe since the 1970s for cerebrovascular insufficiency. A pilot RCT (12-week oral vinpocetine) found improved cerebrovascular reserve capacity and cognitive status in patients with chronic cerebral hypoperfusion.

Vitamin B12 is essential for homocysteine metabolism; deficiency elevates homocysteine, which is associated with endothelial dysfunction, atherosclerosis, and increased cardiovascular risk. B12 supplementation reliably lowers homocysteine, but clinical trials have produced mixed results on hard cardiovascular endpoints. A meta-analysis of B-vitamin supplementation in stroke patients showed a significant 11% reduction in combined risk of stroke, MI, and vascular death.

Niacin (nicotinic acid) at doses causing the 'niacin flush' produces clinically significant peripheral vasodilation through prostaglandin D2 and E2-mediated mechanisms. The flush represents genuine skin microvascular blood flow enhancement. Lower doses of immediate-release niacin (100–500 mg) can improve peripheral circulation and skin microvascular blood flow. High-dose niacin raises HDL and improves lipid profiles, indirectly supporting vascular health.

Vitamin C enhances endothelial function and nitric oxide bioavailability, improving arterial vasodilation and blood flow. Meta-analyses of RCTs document modest reductions in blood pressure and improvements in endothelial function, including in patients with hypertension and coronary artery disease.

Watermelon's L-citrulline raises plasma L-arginine and nitric oxide, supporting vasodilation and peripheral blood flow. Clinical evidence shows improvements in vascular function parameters including flow-mediated dilation and reduced peripheral vascular resistance in cardiovascular-risk populations.

Yarrow demonstrates vasodilatory, antihypertensive, and vasoprotective pharmacological activity in multiple preclinical models, mediated by calcium channel blockade, endothelial NO release, and flavonoid-driven peripheral vasodilation. It is described in European herbalism as a circulatory stimulant and peripheral vasodilator.

Yohimbine has documented effects on peripheral circulation, primarily increasing norepinephrine spillover and raising blood pressure by blocking α2-adrenergic receptors. It has been studied for neurogenic orthostatic hypotension, where it can delay the blood pressure fall on standing by increasing sympathetic tone. Increased forearm blood flow at rest has been observed in controlled human studies.

Traditional Chinese medicine employs A. galanga (lesser galangal) to 'invigorate the circulatory system' and treat cold-related blood stagnation. Constituents of the plant act as platelet-activating factor (PAF) antagonists in vitro, which may partially explain this use. No dedicated human cardiovascular circulation trials exist.

Early North American settlers and European folk traditions used arnica tinctures to improve circulation and treat superficial vascular inflammation. The EMA report documents medieval use for cardiovascular and circulatory conditions. Helenalin inhibits platelet aggregation in vitro, a pharmacologically relevant circulatory mechanism. The German Commission E approves arnica for superficial phlebitis, a local circulatory condition.

Black pepper is classified in Ayurveda and traditional Chinese medicine as a warming, circulatory-stimulant herb. The Trikatu formula including black pepper is specifically indicated for stimulating circulation. Modern pharmacological data on piperine's cardiovascular effects (blood pressure, lipid profiles) provide partial mechanistic support.

Corn silk has traditionally been used to support circulation indirectly through its diuretic action, which reduces fluid load and blood volume, and through traditional use for cardiovascular conditions including congestive heart failure. Modern research supporting direct circulatory effects beyond blood pressure is limited to animal studies.

Geranium EO is described in multiple traditional and herbal sources as a circulatory stimulant that increases blood flow and relieves congestion. A clinical trial context review notes its use for blood congestion relief and circulation improvement. No RCT directly evaluates this effect.

Horseradish is classified in traditional herbal medicine as a circulatory stimulant. The isothiocyanates are described as thermogenic and vasodilatory, improving peripheral blood flow. Herbal Reality documents improved tissue blood flow with hot isothiocyanate-containing remedies. No dedicated human clinical trials for circulatory endpoints.

Traditional use of huckleberry and closely related bilberry consistently emphasized improving peripheral circulation, reducing capillary fragility, and reversing poor blood supply—attributed to the berry's anthocyanosides strengthening capillary walls. Huckleberry has been documented in European botanical traditions as a pre-surgical agent to reduce bleeding risk and improve blood supply to peripheral tissues.

Inositol nicotinate (hexanicotinate, 'flush-free niacin') is a bound form of niacin marketed for circulatory support, particularly for peripheral vascular disease and Raynaud's phenomenon. Traditional and older clinical use for peripheral circulation preceded modern pharmacological evaluation. However, unlike nicotinic acid, inositol nicotinate does not consistently release free niacin at sufficient levels to replicate the vasodilatory flush effect, making its evidence base weaker.

In TCM, moxibustion with A. vulgaris is believed to stimulate blood flow and qi at acupuncture points, and this is one of its central traditional mechanisms. The antithrombotic properties of borneol (a constituent of the essential oil) are documented in vitro. European medieval medicine used mugwort to 'remove leg fatigue.' No oral supplementation circulation trials exist.

Peach kernel (Tao Ren) is one of the primary blood-invigorating herbs in TCM, used to promote blood circulation and remove blood stasis. This is among the most long-standing and centrally documented traditional uses across multiple classical TCM texts.

Prickly ash is classified in traditional herbalism as a circulatory stimulant, used for peripheral circulatory insufficiency including cold hands and feet, intermittent claudication, and Raynaud's syndrome. Both RxList and multiple herbal monographs document this traditional use. The compound nitidine in Zanthoxylum has been cited as contributing to its cardiovascular tonic action. No human clinical trials have been conducted.

Red clover was historically regarded as a 'blood purifier' and circulatory tonic across multiple herbal traditions. Drugs.com records that it was 'thought to purify the blood by promoting urine and mucus production, improving circulation.' Scientific evidence for arterial compliance improvement provides partial modern support for the circulation link.

Rosemary has a deeply established traditional reputation for stimulating circulation, particularly to the head and periphery. It is classified as a circulatory stimulant in European herbal traditions and the PMC literature confirms its historical use for poor circulation. Topical use is recognized by the EMA for local stimulation of blood flow.

In traditional Chinese medicine, shiitake is used to nourish the blood and improve circulation. Modern research has identified adenosine in shiitake as an inhibitor of platelet aggregation, a mechanism that could support healthy blood flow. Animal model data support anti-clotting effects; human circulatory trials are lacking.

TCM records Z. bungeanum (Hua Jiao) as promoting blood circulation and warming the body. Modern pharmacological reviews acknowledge its cardiovascular pharmacological effects, and its use in circulatory promotion is documented across classical texts and the Chinese Pharmacopoeia.

Improving blood circulation is a documented traditional use of smartweed, supported by its content of rutin, a flavonoid known to strengthen capillary walls and reduce vascular fragility. Traditional use for strengthening fragile blood vessels is well-documented.

Ayurvedic tradition credits Triphala with improving blood circulation and strengthening capillaries. Animal studies show Triphala reduces myocardial necrosis and improves vascular markers. Triphala may also increase red blood cell production and hemoglobin. Direct controlled human evidence for circulation improvement is absent.

Watercress has traditional use for supporting circulation, and its dietary nitrate content provides a mechanistic basis via the nitrate-nitrite-nitric oxide vasodilation pathway. Traditional herbal records document watercress for circulatory health. Scientific evidence for nitrate-mediated vasodilation exists for the class of nitrate-rich vegetables but not in dedicated watercress circulation trials.

Poor circulation is listed among the traditional oral indications for yucca by Rxlist, Drugs.com, and multiple pharmacological reference sources. Yucca phenolics have demonstrated antiplatelet activity in vitro (inhibiting platelet adhesion and aggregation), which could support vascular flow. However, no human circulation-specific clinical trial exists.

Zanthoxylum species have traditional use in Chinese medicine for improving blood circulation, described as 'warming meridians' and 'moving qi and blood.' This is supported by preliminary vasodilatory and antihypertensive effects in preclinical models, with no dedicated circulation clinical studies.